Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Virtus LifeSci Biotech Clinical Trials ETF Share Price

BBC

PCQ

$44.5673

+$0.87

(1.98%)

Provider: Virtus Category: Health

Overview Returns Holdings Sector Breakdown FAQs

Price Chart

Key Metrics

Expense Ratio info-icon

The expense ratio is how much you pay a mutual fund or ETF per year, expressed as a percent of your investments. It is a measure of the fund's operating costs relative to assets.

0.79%

Volume

This is the total number of shares traded during the most recent trading day.

9.73K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

1.49%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.22

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$18.01 L

$48.18 H

$44.5673

About Virtus LifeSci Biotech Clinical Trials ETF, ETF

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. more

Provider: VirtusCategory: Health

Returns

Time Frame	BBC	S&P500
1-Week Return	2.32%	1.22%
1-Month Return	2.08%	6.06%
3-Month Return	3.48%	9.92%
6-Month Return	19.43%	10.93%
1-Year Return	135.96%	27.95%
3-Year Return	81.94%	79.77%
5-Year Return	-8.6%	79.85%
10-Year Return	108.69%	260.4%

Time Frame	BBC	S&P500
1-Week Return	230.65%	88.19%
1-Month Return	28.46%	104.59%
3-Month Return	14.88%	46.75%
6-Month Return	43.34%	23.41%
1-Year Return	135.96%	27.95%
3-Year Return	22.08%	21.59%
5-Year Return	-1.78%	12.46%
10-Year Return	7.63%	13.68%

Largest Holdings

Stock name	Ticker	Weight
Erasca Inc	ERAS	2.55%
Enliven Therapeutics Inc	ELVN	1.81%
Dianthus Therapeutics Inc	DNTH	1.62%
Spyre Therapeutics Inc	SYRE	1.61%
Tango Therapeutics Inc	TNGX	1.61%
Revolution Medicines Inc	RVMD	1.48%
Oruka Therapeutics Inc	ORKA	1.45%
Definium Therapeutics Inc	DFTX	1.41%
Alumis Inc	ALMS	1.4%
Liquidia Corp	LQDA	1.4%
Rezolute Inc	RZLT	1.37%
Compass Pathways Plc	CMPS	1.33%
Relay Therapeutics Inc	RLAY	1.3%
GH Research PLC	GHRS	1.29%
AbCellera Biologics Inc	ABCL	1.19%
Kodiak Sciences Inc	KOD	1.14%
Intellia Therapeutics Inc	NTLA	1.14%
Tectonic Therapeutic Inc	TECX	1.14%
Centessa Pharmaceuticals PLC	CNTA	1.13%
Corvus Pharmaceuticals Inc	CRVS	1.13%
Allogene Therapeutics Inc	ALLO	1.12%
CG oncology Inc	CGON	1.12%
Tyra Biosciences Inc	TYRA	1.09%
Vir Biotechnology Inc	VIR	1.07%
Edgewise Therapeutics Inc	EWTX	1.06%
Jade Biosciences Inc	JBIO	1.05%
Neurogene Inc	NGNE	0.99%
Praxis Precision Medicines Inc	PRAX	0.99%
Inhibrx Biosciences Inc	INBX	0.98%
Rapport Therapeutics Inc	RAPP	0.98%
Cullinan Therapeutics Inc	CGEM	0.97%
uniQure NV	QURE	0.96%
AnaptysBio Inc	ANAB	0.95%
Immunovant Inc	IMVT	0.95%
MoonLake Immunotherapeutics	MLTX	0.95%
Celcuity Inc	CELC	0.94%
Xenon Pharmaceuticals Inc	XENE	0.94%
Pharvaris NV	PHVS	0.93%
Precigen Inc	PGEN	0.92%
Septerna Inc	SEPN	0.92%
Cytokinetics Inc	CYTK	0.91%
Beam Therapeutics Inc	BEAM	0.9%
Monte Rosa Therapeutics Inc	GLUE	0.9%
Nektar Therapeutics	NKTR	0.9%
Bicara Therapeutics Inc	BCAX	0.89%
Palvella Therapeutics Inc	PVLA	0.89%
Denali Therapeutics Inc	DNLI	0.88%
Celldex Therapeutics Inc	CLDX	0.87%
Immunome Inc	IMNM	0.87%
Vaxcyte Inc	PCVX	0.86%
Immatics NV	IMTX	0.86%
Arcus Biosciences Inc	RCUS	0.86%
MeiraGTx Holdings plc	MGTX	0.84%
Capricor Therapeutics Inc	CAPR	0.84%
ArriVent Biopharma Inc	AVBP	0.83%
Omeros Corp	OMER	0.83%
Amylyx Pharmaceuticals Inc	AMLX	0.82%
Annexon Inc	ANNX	0.81%
MBX Biosciences Inc	MBX	0.8%
Scholar Rock Holding Corp	SRRK	0.8%
Protagonist Therapeutics Inc	PTGX	0.79%
Belite Bio Inc	BLTE	0.79%
Nuvalent Inc	NUVL	0.79%
AtaiBeckley Inc	ATAI	0.77%
Taysha Gene Therapies Inc	TSHA	0.77%
Apogee Therapeutics Inc	APGE	0.76%
Ironwood Pharmaceuticals Inc	IRWD	0.76%
Zymeworks Inc	ZYME	0.75%
Sionna Therapeutics Inc	SION	0.75%
Summit Therapeutics Inc	SMMT	0.75%
Stoke Therapeutics Inc	STOK	0.73%
Arbutus Biopharma Corp	ABUS	0.73%
Janux Therapeutics Inc	JANX	0.72%
Prothena Corp PLC	PRTA	0.72%
Dyne Therapeutics Inc	DYN	0.72%
Newamsterdam Pharma Co NV	NAMS	0.72%
Nurix Therapeutics Inc	NRIX	0.7%
Kymera Therapeutics Inc	KYMR	0.68%
ORIC Pharmaceuticals Inc	ORIC	0.68%
Rocket Pharmaceuticals Inc	RCKT	0.67%
Biohaven Ltd	BHVN	0.67%
CytomX Therapeutics Inc	CTMX	0.67%
Xeris Biopharma Holdings Inc	XERS	0.66%
Viking Therapeutics Inc	VKTX	0.65%
Monopar Therapeutics Inc	MNPR	0.65%
Ideaya Biosciences Inc	IDYA	0.65%
Mineralys Therapeutics Inc	MLYS	0.64%
EyePoint Inc	EYPT	0.64%
Cogent Biosciences Inc	COGT	0.63%
Prime Medicine Inc	PRME	0.62%
4D Molecular Therapeutics Inc	FDMT	0.62%
ProKidney Corp	PROK	0.62%
Recursion Pharmaceuticals Inc	RXRX	0.6%
Disc Medicine Inc	IRON	0.58%
Assembly Biosciences Inc	ASMB	0.58%
Rigel Pharmaceuticals Inc	RIGL	0.56%
Savara Inc	SVRA	0.55%
Xencor Inc	XNCR	0.55%
Vera Therapeutics Inc	VERA	0.54%
Arvinas Inc	ARVN	0.53%
Maze Therapeutics Inc	MAZE	0.51%
Bicycle Therapeutics PLC	BCYC	0.47%
Sana Biotechnology Inc	SANA	0.46%
Structure Therapeutics Inc	GPCR	0.45%
Altimmune Inc	ALT	0.44%
Viridian Therapeutics Inc	VRDN	0.41%
Keros Therapeutics Inc	KROS	0.4%
Fulcrum Therapeutics Inc	FULC	0.4%
Lexeo Therapeutics Inc	LXEO	0.39%
REGENXBIO Inc	RGNX	0.37%
Invivyd Inc	IVVD	0.37%
Compass Therapeutics Inc	CMPX	0.35%
Replimune Group Inc	REPL	0.35%
Zenas Biopharma Inc	ZBIO	0.34%
Verastem Inc	VSTM	0.34%
WaVe Life Sciences Ltd	WVE	0.29%
Olema Pharmaceuticals Inc	OLMA	0.29%
First Tracks Biotherapeutics Inc	TRAX	0.27%
Upstream Bio Inc	UPB	0.23%
enGene Therapeutics Inc	ENGN	0.16%
Mereo Biopharma Group PLC	MREO	0.12%
Gossamer Bio Inc	GOSS	0.04%
Cash/Cash equivalents	Cash.Cash.equivalents	0.02%

Sector Breakdown

Sector	Weight
Health care	100.00%

Discover more

SPDR S&P 500 ETF Trust

Invesco QQQ Trust

Vanguard Total Stock Market Index Fund ETF Shares

iShares Core MSCI EAFE ETF

Vanguard Total Bond Market Index Fund ETF Shares

iShares Bitcoin Trust

Vanguard Growth Index Fund ETF Shares

SPDR® Gold Shares

iShares 20+ Year Treasury Bond ETF

FAQs

What is Virtus LifeSci Biotech Clinical Trials ETF (BBC) ETF share price today?

Virtus LifeSci Biotech Clinical Trials ETF (BBC) share price today is $44.5673.

Can Indians buy Virtus LifeSci Biotech Clinical Trials ETF shares?

Yes, Indians can buy shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. To buy BBC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.

Can Fractional shares of Virtus LifeSci Biotech Clinical Trials ETF be purchased?

Yes, you can purchase fractional shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. You can start investing in Virtus LifeSci Biotech Clinical Trials ETF (BBC) with a minimum investment of $1.

How to invest in Virtus LifeSci Biotech Clinical Trials ETF shares from India?

Click on Sign Up or Invest in BBC ETF at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Virtus LifeSci Biotech Clinical Trials ETF shares

What is Virtus LifeSci Biotech Clinical Trials ETF's 52-week high and low ETF share price?

The 52-week high price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $48.18. The 52-week low price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $18.01.

What is Virtus LifeSci Biotech Clinical Trials ETF's ticker or symbol?

The stock symbol (or ticker) of Virtus LifeSci Biotech Clinical Trials ETF is BBC.

Can I set up automatic investments (SIP) in Virtus LifeSci Biotech Clinical Trials ETF shares?

Yes, you can setup SIP in Virtus LifeSci Biotech Clinical Trials ETF shares. Follow the below steps to create the SIP:

Sign up on Vested and complete your KYC for US Stocks
Transfer funds to your US Stocks account
Navigate to BBC tickr page and set up your recurring investment

What is the historical performance of Virtus LifeSci Biotech Clinical Trials ETF ETF?

Here is the historical performance of BBC on the Vested app.

1 Year Return - {X%}
3 Year Return
5 Year
You can also access the top holdings, the expense ratio, and the sector breakdown for Virtus LifeSci Biotech Clinical Trials ETF on Vested.

What is the expense ratio of Virtus LifeSci Biotech Clinical Trials ETF?

The expense ratio of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 0.79%.